Now live: Pro — the full 13F research suite for serious investorsSee pricing →
AIGH Capital Management LLC

Q3 2024 · 13F-HR

AIGH Capital Management LLCholdings as filed

Filed 2024-11-13 · accession 0001214659-24-018827

$354.6M
Reported value
40
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
78464A870XBISPDR SER TR$110.4M31.2%500,000PUTSOLE
219350105GLWCORNING INC$30.5M8.60%675,000CALLSOLE
71535D106PSNLPERSONALIS INC$21.5M6.07%3,999,064CommonSOLE
810648105SCPHSCPHARMACEUTICALS INC$18.8M5.30%4,124,367CommonSOLE
00770C101ARQARQ INC$16.5M4.66%2,817,078CommonSOLE
24661P807DCTHDELCATH SYS INC$16.1M4.54%1,782,490CommonSOLE
25400W102APPSDIGITAL TURBINE INC$13.8M3.89%4,490,140CommonSOLE
62857J201MYOMYOMO INC$11.1M3.14%2,778,848CommonSOLE
219350105GLWCORNING INC$10.2M2.87%225,000CommonSOLE
09075X108BIODESIX INC$10.1M2.85%5,679,812CommonSOLE
05479K106ELUTELUTIA INC$9.6M2.70%2,510,442CommonSOLE
15117F807CLRBUSDCELLECTAR BIOSCIENCES INC$6.8M1.93%3,197,394CommonSOLE
87650L103TARSTARSUS PHARMACEUTICALS INC$6.7M1.90%204,413CommonSOLE
872381108TELATELA BIO INC$6.2M1.76%2,469,373CommonSOLE
98422E103XERSXERIS BIOPHARMA HOLDINGS INC$6.2M1.76%2,185,654CommonSOLE
05587G203BKTIBK TECHNOLOGIES CORPORATION$6.2M1.74%282,772CommonSOLE
451622203IPWRIDEAL PWR INC$5.7M1.62%700,000CommonSOLE
28617B606ELVAELECTROVAYA INC$5.7M1.61%2,447,626CommonSOLE
532257805LPTHLIGHTPATH TECHNOLOGIES INC$5.1M1.44%3,723,932CommonSOLE
88338H704TQ80THERATECHNOLOGIES INC$4.6M1.30%3,725,204CommonSOLE
269796108EGRXEAGLE PHARMACEUTICALS INC$4.5M1.27%1,211,509CommonSOLE
22407B108COYACOYA THERAPEUTICS INC$4.2M1.18%649,427CommonSOLE
45817G201IDNINTELLICHECK INC$3.8M1.08%1,767,732CommonSOLE
M8001Q126PYPDPOLYPID LTD$2.4M0.67%679,668CommonSOLE
30041T104MRAMEVERSPIN TECHNOLOGIES INC$2.2M0.62%373,888CommonSOLE
55933J203MXMAGNACHIP SEMICONDUCTOR CORP$2.1M0.59%450,000CommonSOLE
00430K865ACASTI PHARMA INC$1.9M0.54%641,083CommonSOLE
355184102FKWLFRANKLIN WIRELESS CORP$1.8M0.50%390,000CommonSOLE
45258H106IMMXIMMIX BIOPHARMA INC$1.7M0.47%1,123,663CommonSOLE
03836J201APREAPREA THERAPEUTICS INC$1.5M0.42%539,300CommonSOLE
08862L103BEYOND AIR INC$1.4M0.39%3,602,991CommonSOLE
49721T507KPRXKIORA PHARMACEUTICALS INC$935,3310.26%255,555CommonSOLE
09090D301BIOMX INC$882,7080.25%865,400CommonSOLE
72941H509CYTXEURPLUS THERAPEUTICS INC$818,9210.23%560,905CommonSOLE
09077D209BFRIBIOFRONTERA INC$666,9070.19%501,434CommonSOLE
83193D203SMTKSMARTKEM INC$573,7670.16%134,687CommonSOLE
45674E109INABEURIN8BIO INC$452,1530.13%1,674,638CommonSOLE
56624R108MCHXMARCHEX INC$370,4470.10%198,100CommonSOLE
30049G302EVOKEVOKE PHARMA INC$338,7610.10%70,546CommonSOLE
80516T113SVREWSAVERONE 2014 LTD$45,4550.01%568,194CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.